Skip to main content
TipRanks
Go Ultimate75% OFF

Matinas BioPharma (6LJ) Financial Statements

0 Followers

Matinas BioPharma Financial Overview

Matinas BioPharma's market cap is currently $866.66K. The company's EPS TTM is $-18.15; its P/E ratio is -0.05; Matinas BioPharma has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.

Financial overview
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue$ 0.00$ 0.00$ 1.10M$ 3.19M$ 33.00K
Gross Profit$ -456.00K$ -972.00K$ 155.00K$ -13.49M$ -14.55M
Operating Income$ -6.96M$ -20.16M$ -23.77M$ -24.59M$ -24.73M
EBITDA$ -9.89M$ -19.19M$ -22.00M$ -20.10M$ -22.50M
Net Income$ -10.35M$ -24.25M$ -22.94M$ -21.00M$ -23.28M
Balance Sheet
Cash & Short-Term Investments$ 4.00M$ 7.28M$ 13.76M$ 28.81M$ 49.62M
Total Assets$ 7.21M$ 12.64M$ 25.10M$ 78.87M$ 61.33M
Total Debt$ 1.35M$ 2.89M$ 3.56M$ 4.12M$ 4.70M
Net Debt$ -2.65M$ -4.39M$ -1.23M$ -2.76M$ -16.33M
Total Liabilities$ 2.38M$ 5.05M$ 5.86M$ 42.23M$ 8.83M
Stockholders' Equity$ 4.83M$ 7.59M$ 19.25M$ 36.64M$ 52.49M
Cash Flow
Free Cash Flow$ -7.01M$ -15.88M$ -15.50M$ -20.05M$ -15.48M
Operating Cash Flow$ -7.01M$ -15.88M$ -15.28M$ -19.16M$ -15.22M
Investing Cash Flow$ 335.00K$ 9.21M$ 13.24M$ 4.88M$ 16.77M
Financing Cash Flow$ 3.39M$ 9.17M$ -7.00K$ 79.00K$ 6.96M

Currency in USD

Matinas BioPharma Earnings and Revenue History

-30M-15M015M-75000 %-50000 %-25000 %0 %EarningsProfit Margin201720182019202020212022202320242025RevenueEarningsProfit Margin

Matinas BioPharma Liabilities to Assets

030M60M90M0 %20 %40 %60 %LiabilitiesLiabilities to Assets201720182019202020212022202320242025AssetsLiabilitiesLiabilities to Assets

Matinas BioPharma Cash Flow

-50M-25M025M50M75M201720182019202020212022202320242025OperatingInvestingFinancing

Matinas BioPharma Forecast EPS vs Actual EPS

-1.7-1.5-1.2-1-0.7-0.5-0.20Q3 24Q4 24Q1 25Q2 25Q1 26EPS EstimateBeatMiss